The Effect of Serial Casting and Physical Therapy in Children With Idiopathic Toe Walking

The Effect of Serial Casting and Physical Therapy on Ankle Range of Motion, Toe Walking Severity, Walking Balance, Functional Health Related Quality of Life in Children With Idiopathic Toe Walking

Children who continue to walk on their tiptoes after developing a heel-toe gait normally are diagnosed with idiopathic toe walking (ITW). The study's aim was to investigate the effects of serial casting and physical therapy on joint range of motion (ROM), toe walking severity, functional health and health-related quality of life, walking balance, and satisfaction from treatment in ITW, in comparison with the control group.

Study Overview

Status

Not yet recruiting

Detailed Description

Children with ITW aged 3-10 years are randomized into three groups: the serial casting group (n=10), the physical therapy group (n=10), and the wait-list control group (n=10). Patients with ankle contracture and previous interventions are excluded. The serial casting group is planned to receive intermittent serial casting once every three days for three weeks. The physical therapy group is planned to undergo three sessions per week for three weeks, consisting of stretching exercises, strengthening exercises, balance training, proprioception exercises, and walking on heels. The patients were assessed by blinded investigators at before treatment (BT), post-treatment (PT: 3th week), 1st month (1MPT), 3rd months (3MPT), and 6th months post-treatment (6MPT). To ensure ethical considerations, only control group was followed-up until the 1MPT.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Istanbul, Turkey, 34752
        • Fatih Sultan Mehmet Trainig and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Aged 3-10 years
  2. Patients with idiopathic toe walking diagnosis
  3. To be evaluated by a pediatric neurologist, not to have abnormal findings in cranial and all spinal magnetic resonance imaging and electrophysiological examinations performed when deemed necessary, and creatinine kinase values are within normal limits ((Absence of any neurological, orthopedic or psychiatric pathology to explain the toe walking pattern (cerebral palsy, neuropathy, myopathy, autism, developmental disorders, etc.)

Exclusion Criteria:

  1. Have previously conservative or surgical treatment
  2. Presence of plantar flexion contracture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Serial Casting
The serial casting group received intermittent serial casting once every three days for three weeks.
A short leg cast is applied to the serial casting group by an orthopedic specialist once every three days for three weeks.
Active Comparator: Exercise
The physical therapy group underwent three sessions per week for three weeks, consisting of stretching exercises, strengthening exercises, balance training, proprioception exercises, and walking on heels.
Stretching exercises, strengthening exercises, balance exercises, proprioception exercises, and heel walking exercises are applied to the physical therapy group for 3 weeks with a physiotherapist for 3 sessions a week.
No Intervention: Control Group
This group consists of the patients on the waitlist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion (ROM)
Time Frame: Day 0
Ankle dorsiflexion ROM with extended knee
Day 0
Range of Motion (ROM)
Time Frame: 3rd week
Ankle dorsiflexion ROM with extended knee
3rd week
Range of Motion (ROM)
Time Frame: 7th week
Ankle dorsiflexion ROM with extended knee
7th week
Range of Motion (ROM)
Time Frame: 15th week
Ankle dorsiflexion ROM with extended knee
15th week
Range of Motion (ROM)
Time Frame: 27th week
Ankle dorsiflexion ROM with extended knee
27th week
Range of Motion (ROM)
Time Frame: Day 0
Ankle dorsiflexion ROM with flexed knee
Day 0
Range of Motion (ROM)
Time Frame: 3rd week
Ankle dorsiflexion ROM with flexed knee
3rd week
Range of Motion (ROM)
Time Frame: 7th week
Ankle dorsiflexion ROM with flexed knee
7th week
Range of Motion (ROM)
Time Frame: 15th week
Ankle dorsiflexion ROM with flexed knee
15th week
Range of Motion (ROM)
Time Frame: 27th week
Ankle dorsiflexion ROM with flexed knee
27th week
Toe Walking Severity Scale
Time Frame: Day 0

The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike

Day 0
Toe Walking Severity Scale
Time Frame: 3rd week

The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike

3rd week
Toe Walking Severity Scale
Time Frame: 7th week

The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike

7th week
Toe Walking Severity Scale
Time Frame: 15th week

The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike

15th week
Toe Walking Severity Scale
Time Frame: 27th week

The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike

27th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric Outcomes Data Collection Instrument (PODCI)
Time Frame: Day 0
PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.
Day 0
Pediatric Outcomes Data Collection Instrument (PODCI)
Time Frame: 3rd week
PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.
3rd week
Pediatric Outcomes Data Collection Instrument (PODCI)
Time Frame: 7th week
PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.
7th week
Pediatric Outcomes Data Collection Instrument (PODCI)
Time Frame: 15th week
PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.
15th week
Pediatric Outcomes Data Collection Instrument (PODCI)
Time Frame: 27th week
PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.
27th week
Tandem Walk Test
Time Frame: Day 0
The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.
Day 0
Tandem Walk Test
Time Frame: 3rd week
The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.
3rd week
Tandem Walk Test
Time Frame: 7th week
The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.
7th week
Tandem Walk Test
Time Frame: 15th week
The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.
15th week
Tandem Walk Test
Time Frame: 27th week
The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.
27th week
Visual Analog Scale
Time Frame: 3rd week
All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)
3rd week
Visual Analog Scale
Time Frame: 7th week
All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)
7th week
Visual Analog Scale
Time Frame: 15th week
All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)
15th week
Visual Analog Scale
Time Frame: 27th week
All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)
27th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Esra Giray, Fatih Sultan Mehmet training and Research Hospital, Istanbul-Turkey

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2023

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

April 15, 2024

Study Registration Dates

First Submitted

August 21, 2023

First Submitted That Met QC Criteria

August 23, 2023

First Posted (Actual)

August 24, 2023

Study Record Updates

Last Update Posted (Actual)

August 24, 2023

Last Update Submitted That Met QC Criteria

August 23, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • illeezozge

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Toe Walking

Clinical Trials on Serial Casting

Subscribe